CreditReports.dk
HomeScreen companies

ELDON BIOLOGICALS A/S Financials, key figures and credit report

CVR number: 26747007 Established 2002 Industry: 20 Manufacture of chemicals and chemical products
Company contact details
Sandtoften 10, 2820 Gentofte
Gross profit 13 231.9 kDKK FY 2025 -3% vs 2024
EBIT 3 836.5 kDKK FY 2025 -17% vs 2024
Net debt -17 694.8 kDKK FY 2025 +26.1% vs 2024
Quick ratio 7.9 FY 2025 -2.9 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit16 382.6512 307.3914 865.4913 635.0613 231.94
Employee benefit expenses-6 163.43-5 555.69-7 407.28-8 942.09-9 317.71
Other operating expenses-15.91
Total depreciation- 391.22- 405.24- 352.66-71.51-77.69
EBIT9 828.006 346.467 089.644 621.463 836.54
Other financial income594.311 096.491 668.241 327.74158.06
Other financial expenses-4 376.83- 447.56- 255.32- 925.59- 771.72
Net income from associates (fin.)142.14- 142.14
Pre-tax profit6 187.626 853.248 502.565 023.613 261.34
Income taxes-1 215.80-1 490.58-1 828.92-1 123.25- 667.69
Net earnings4 971.825 362.666 673.643 900.352 593.65

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure2 786.625 284.965 788.299 280.76
Intangible assets total2 786.625 284.965 788.299 280.76
Machinery and equipment781.94462.20170.63178.23269.40
Tangible assets total781.94462.20170.63178.23269.40
Holdings in group member companies142.14
Investments total338.01222.15229.83242.00231.25
Long term receivables total
Finished products/goods2 132.492 850.013 080.652 905.652 778.67
Advance payments17.50
Inventories total2 149.992 850.013 080.652 905.652 778.67
Current trade debtors2 672.072 243.042 147.616 199.438 571.78
Current amounts owed by group member comp.1 377.473 375.478 633.818 178.919 025.55
Prepayments and accrued income113.17222.64167.00170.17452.32
Current other receivables350.46384.80537.92273.06550.41
Short term receivables total4 513.166 225.9511 486.3414 821.5718 600.06
Other current investments2 948.183 956.874 616.445 552.014 513.26
Cash and bank deposits24 750.2823 083.8321 844.3218 387.7113 477.93
Cash and cash equivalents27 698.4727 040.7026 460.7623 939.7217 991.19
Balance sheet total (assets)35 481.5839 587.6346 713.1747 875.4649 151.32

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital500.00500.00500.00500.00500.00
Shares repurchased500.001 000.002 000.002 000.002 000.00
Other reserves2 786.624 735.325 127.927 851.98
Retained earnings23 647.4724 832.6726 246.6330 527.6729 703.97
Profit of the financial year4 971.825 362.666 673.643 900.352 593.65
Shareholders equity total29 619.2934 481.9540 155.6042 055.9542 649.60
Provisions139.97162.01693.32793.021 431.43
Non-current accruals and deferred income340.40407.40407.40
Non-current deferred tax liabilities1 023.5529.27
Non-current liabilities total340.401 430.95436.67
Current loans from credit institutions34.431.24296.35
Advances received103.89
Current trade creditors1 538.561 252.621 215.631 261.151 357.56
Current owed to participating913.90521.93113.98
Current owed to group member4.44633.98
Short-term deferred tax liabilities1 221.441 466.461 293.351 023.55
Other non-interest bearing current liabilities1 944.531 663.792 266.922 333.151 956.15
Current liabilities total5 722.314 943.665 523.863 595.544 633.61
Balance sheet total (liabilities)35 481.5839 587.6346 713.1747 875.4649 151.32
Page generated